Correlation Between Spyre Therapeutics and Bayer AG
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Bayer AG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Bayer AG into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and Bayer AG, you can compare the effects of market volatilities on Spyre Therapeutics and Bayer AG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Bayer AG. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Bayer AG.
Diversification Opportunities for Spyre Therapeutics and Bayer AG
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Spyre and Bayer is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Bayer AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bayer AG and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Bayer AG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bayer AG has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Bayer AG go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and Bayer AG
Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Bayer AG. In addition to that, Spyre Therapeutics is 1.69 times more volatile than Bayer AG. It trades about -0.13 of its total potential returns per unit of risk. Bayer AG is currently generating about 0.3 per unit of volatility. If you would invest 1,965 in Bayer AG on October 26, 2024 and sell it today you would earn a total of 238.00 from holding Bayer AG or generate 12.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spyre Therapeutics vs. Bayer AG
Performance |
| Timeline |
| Spyre Therapeutics |
| Bayer AG |
Spyre Therapeutics and Bayer AG Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spyre Therapeutics and Bayer AG
The main advantage of trading using opposite Spyre Therapeutics and Bayer AG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Bayer AG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bayer AG will offset losses from the drop in Bayer AG's long position.| Spyre Therapeutics vs. BRP Inc | Spyre Therapeutics vs. PACCAR Inc | Spyre Therapeutics vs. Magna International | Spyre Therapeutics vs. Cars Inc |
| Bayer AG vs. Albertsons Companies | Bayer AG vs. Spyre Therapeutics | Bayer AG vs. Bridgford Foods | Bayer AG vs. John B Sanfilippo |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |